Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators

US9822130B2 · kind B2 · utility

Assignee

• Merck Sharp & Dohme LLC · US

Inventors

• Raphaelle Berger · New York, US
• Guizhen Dong
• Subharekha Raghavan · Teaneck, US
• Zhiqiang Yang · Westfield, US

Key dates

• Filing date: Nov 19, 2015
• Grant date: Nov 21, 2017
• Expiry date: Dec 11, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A compound of Formula Ior a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.